Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Sarepta’s big bet on Arrowhead’s siRNA assets yields early data

Sarepta’s big bet on Arrowhead’s siRNA assets yields early data

  • March 25, 2026

Sarepta Therapeutics has shared initial clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision to bet big on Arrowhead Pharmaceuticals’ pipeline.

Leave A Comment

Fields (*) Mark are Required